Professor of Medicines Discovery, University of Edinburgh.
Joined December 2019
- Tweets51
- Following78
- Followers70
- Likes57
Jonathan is an excellent addition to the @KynosTxLtd team. I look forward to working together to build further success.
This Post is from an account that no longer exists. Learn more
Proud to have been part of the team responsible for developing this medicine. Really encouraging results for those affected by Alzheimer's disease.
Watch webcast for a more in-depth look at this exciting news for @ActinogenMed announcing positive Ph 2a clinical data from its #AlzheimersDisease #biomarker study, which validates the Company’s Xanamem program.
#clinicaltrials #investors $ACW #ASX
youtube.com/watch?v=lxERxCNp…
Scott Webster retweeted
... and on the same day here are the encouraging clinical trial results from the drug that we developed to reduce cortisol action in the brain of patients with dementia @prof_webster actinogen.com.au/
Scott Webster retweeted
Kynos is rapidly building momentum towards the clinic. Alison’s experience across large pharma and #biotech covers #finance at the #operational level as well as a #strategic outlook. A breadth of skill and experience to support Kynos achieve a strong position in the near future.
This Post is from an account that no longer exists. Learn more
Scott Webster retweeted
Enamine is resuming work.
Please review the new statement from our Founder and CEO, Andrey Tolmachev.
bit.ly/3KkVeIq
Scott Webster retweeted
"Supporting companies such as Kynos Therapeutics to progress its ground-breaking medical research is a priority for @scotent" - our Director of Growth Investments, Kerry Sharp on the @EdinburghUni spin-out's financing announcement today: bit.ly/3jejsIr
Really happy to have support from @scotent to build our company
.@KynosTxLtd has secured £9 million to commercialise its ground-breaking drug discovery research 🤩
We’re delighted to have contributed to the funding which will help Kynos expand its team and develop a portfolio of medicines.
#Investment #WorldHealthDay
ow.ly/UvH250ICFiP
Scott Webster retweeted
New portfolio company @KynosTxLtd with @epidarex @scotent @DamianJMole @prof_webster. Excited to support & you can read more here: bit.ly/3NVhsmo. #backinginnovation
👇
thetimes.co.uk/article/kynos…
Scott Webster retweeted
Great news on #WorldHealthDay with investment in new co @KynosTxLtd. Excited to support & you can read more here: bit.ly/3NVhsmo. #backinginnovation @epidarex @scotent
👇
University of Edinburgh life sciences spin-out secures major £9m injection scotsman.com/business/univer…
Scott Webster retweeted
Kynos Therapeutics, a life sciences spin-out from @EdinburghUni, has emerged from 'stealth mode' with £9m to finance its next phase of growth insider.co.uk/news/edinburgh…
Delighted to announce this investment into @KynosTxLtd
This Post is from an account that no longer exists. Learn more
These updates are great if you like to keep abreast of the latest advances in med chem
Molecules of the Month, Jul 2021 | bit.ly/SMOTM2107
An ER degrader in Ph. III, 4(!) neurology candidates from Takeda, two sulfoximines, and molecule gets ubiquitylated to degrade its target
Gradually moving content to team page @drughuntersite
#chemtwitter #biotwitter
Very pleased to be the academic lead on this. A great platform to advance drug discovery and develop spinout opportunities alongside world-leading companies
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
This is good on the Ox/AZ vaccine journey
"AstraZeneca were like the gang that couldn’t shoot straight.” Spectacular behind-the-scenes reporting here by @journosooz and @StephaniBaker on the many trials and tribulations of "one of the most closely watched scientific projects in history."
bloomberg.com/news/features/… via @BW